Australia markets open in 6 hours 51 minutes

NextCure, Inc. (NXTC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3600+0.1500 (+12.43%)
As of 01:06PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 34.32M
Enterprise value -67.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.30
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.05

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 3-20.39%
S&P500 52-week change 323.10%
52-week high 32.5700
52-week low 30.9800
50-day moving average 31.7096
200-day moving average 31.4320

Share statistics

Avg vol (3-month) 3300.32k
Avg vol (10-day) 3162.96k
Shares outstanding 527.9M
Implied shares outstanding 627.9M
Float 820.77M
% held by insiders 18.82%
% held by institutions 151.65%
Shares short (15 Apr 2024) 4113.23k
Short ratio (15 Apr 2024) 40.26
Short % of float (15 Apr 2024) 40.41%
Short % of shares outstanding (15 Apr 2024) 40.41%
Shares short (prior month 15 Mar 2024) 4839.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.08%
Return on equity (ttm)-44.49%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -63.95M
Net income avi to common (ttm)-62.72M
Diluted EPS (ttm)-2.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)108.3M
Total cash per share (mrq)3.88
Total debt (mrq)6.61M
Total debt/equity (mrq)5.77%
Current ratio (mrq)16.38
Book value per share (mrq)4.10

Cash flow statement

Operating cash flow (ttm)-52.97M
Levered free cash flow (ttm)-33.96M